Notice2023-22584
Meeting of the Advisory Commission on Childhood Vaccines
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 12, 2023
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Commission on Childhood Vaccines (ACCV) will hold public meetings for the 2024 calendar year (CY). Information about ACCV, agendas, and materials for these meetings can be found on the ACCV website at https://www.hrsa.gov/advisory- committees/vaccines/index.html.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 196 (Thursday, October 12, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 196 (Thursday, October 12, 2023)]
[Notices]
[Pages 70680-70681]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-22584]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Commission on Childhood Vaccines
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Commission on Childhood Vaccines
(ACCV) will hold public meetings for the 2024 calendar year (CY).
Information about ACCV, agendas, and materials for these meetings can
be found on the ACCV website at <a href="https://www.hrsa.gov/advisory-committees/vaccines/index.html">https://www.hrsa.gov/advisory-committees/vaccines/index.html</a>.
DATES: ACCV meetings will be held on March 7, 2024, 10:00 a.m.-4:00
p.m. Eastern Time (ET); March 8, 2024, 10:00 a.m.-4:00 p.m. ET;
September 5, 2024, 10:00 a.m.-4:00 p.m. ET; September 6, 2024, 10:00
a.m.-4:00 p.m. ET.
ADDRESSES: Meetings may be held in-person or by Zoom webinar. For
updates on how the meeting will be held, visit the ACCV website meeting
page included below 30 business days before the date of the meeting,
where instructions for joining meetings either in-person or remotely
will be posted. In-person ACCV meetings will be held at 5600 Fishers
Lane, Rockville, MD 20857. For meeting information updates, go to the
ACCV website meeting page at <a href="https://www.hrsa.gov/advisory-committees/vaccines/meetings.html">https://www.hrsa.gov/advisory-committees/vaccines/meetings.html</a>.
FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison,
Division of Injury Compensation Programs, HRSA, 5600 Fishers Lane, 8W-
25A, Rockville, MD 20857; 800-338-2382; or <a href="/cdn-cgi/l/email-protection#5a1b19190c1a3228293b743d352c"><span class="__cf_email__" data-cfemail="fdbcbebeabbd958f8e9cd39a928b">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: ACCV provides advice and recommendations to
the Secretary of HHS (Secretary) on policy, program development, and
other issues related to implementation of the National Vaccine Injury
Compensation Program and concerning other matters as described under
section 2119 of the Public Health Service Act (42 U.S.C. 300aa-19).
Since priorities dictate meeting times, be advised that start
times, end times, and agenda items are subject to change. For CY 2024
meetings, agenda items may include, but are not limited to: updates
from the Division of Injury Compensation Programs, Department of
Justice, Office of Infectious Disease and HIV/AIDS Policy (HHS),
Immunization Safety Office (Centers for Disease Control and
Prevention), National Institute of Allergy and Infectious Diseases
(National Institutes of Health) and Center for Biologics Evaluation and
Research (Food and Drug Administration). Refer to the ACCV website
listed above for all current and updated information concerning the CY
2024 ACCV meetings, including draft agendas and meeting materials that
will be posted 5 calendar days before the meeting.
These meetings are open to the public. Meetings held by Zoom
webinar will require registration. Registration details will be
provided on our ACCV website at <a href="https://www.hrsa.gov/advisory-committees/vaccines/meetings.html">https://www.hrsa.gov/advisory-committees/vaccines/meetings.html</a>. All registrants will be asked to
provide their name, affiliation, and email address. After registration,
individuals will receive personalized Zoom information via email.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting(s). Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to ACCV should
[[Page 70681]]
be sent to Pita Gomez using the contact information listed above at
least 5 business days before the meeting date(s).
Individuals who need special assistance or another reasonable
accommodation should notify Pita Gomez using the contact information
listed above at least 10 business days before the meeting(s) they wish
to attend. Since all in-person meetings will occur in a federal
government building, attendees must go through a security check to
enter the building. Non-U.S. Citizen attendees must notify HRSA of
their planned attendance at least 20 business days prior to the meeting
to facilitate their entry into the building. All attendees are required
to present government-issued identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-22584 Filed 10-11-23; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 12, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.